PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects (GLA5PR-102)

This study has been completed.
Information provided by (Responsible Party):
GL Pharm Tech Corporation Identifier:
First received: July 9, 2012
Last updated: November 11, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)